Key facts
| Price (PPV) | 160.90 MAD |
|---|---|
| Dispensing status | Schedule A — prescription only |
| Composition (DCI) | irbesartanhydrochlorothiazide |
| Class | Agents acting on the renin-angiotensin system |
| ATC code | C09DA04 |
| Manufacturer | ZENITH PHARMA |
| Presentation | Boite de 30 |
| Nature | Médicament |
| Hospital price | 100.50 MAD |
| Data collected on | 9/8/2026 |
Indications
Traitement de l’hypertension artérielle essentielle. Cette association à dose fixe est indiquée chez les patients adultes dont la pression artérielle est insuffisamment contrôlée par l’irbésartan seul ou l’hydrochlorothiazide seul.
Find an open pharmacy
On-call pharmacies near you
Same-strength alternatives — cheapest first
Co-Arapro 300 mg / 25 mg (ZENITH PHARMA) contains the same active substance as Co-Arapro 300 mg / 25 mg (Irbesartan | Hydrochlorothiazide) at the same strength, but in a different pack: Boite de 10 at 62.40 MAD, i.e. 6.24 MAD per unit against 5.36 MAD for Co-Arapro 300 mg / 25 mg. The public sale price is set by the Ministry of Health: it is identical in every pharmacy.
Same pack size
| Product | Manufacturer | Pack | PPV | Unit price | Difference |
|---|---|---|---|---|---|
| Coavacor 300 mg / 25 mg | POLYMEDIC | Boite de 30 | 160.90 MAD | 5.36 / unit | — |
| Irphi Plus 300 mg / 25 mg | PHI | Boite de 30 | 160.90 MAD | 5.36 / unit | — |
| Novortan Plus 300 mg / 25 mg | NOVOPHARMA | Boite de 30 | 160.90 MAD | 5.36 / unit | — |
Other pack sizes
| Product | Manufacturer | Pack | PPV | Unit price |
|---|---|---|---|---|
| Co-Arapro 300 mg / 25 mg | ZENITH PHARMA | Boite de 10 | 62.40 MAD | 6.24 / unit |
| Co-Irvel 300 mg / 25 mg | AFRIC-PHAR | Boite de 14 | 85 MAD | 6.07 / unit |
| Co-Irbesar Sun 300 mg / 25 mg | SUN PHARMACEUTICALS NORTH AFRICA S.A | Boite de 28 | 153.60 MAD | 5.49 / unit |
| Co-Irvel 300 mg / 25 mg | AFRIC-PHAR | Boite de 28 | 153.60 MAD | 5.49 / unit |
| Co-Vepran 300 mg / 25 mg | SOTHEMA | Boite de 28 | 153.60 MAD | 5.49 / unit |
Substituting a generic is the pharmacist's decision; for medicines listed in schedules A, B and C it still requires a prescription. Public sale prices published by the Directorate of Medicines and Pharmacy, recorded on 9/8/2026.
About Co-Arapro 300 mg / 25 mg
Co-Arapro 300 mg / 25 mg belongs to the agents acting on the renin-angiotensin system therapeutic class. In Morocco, this drug is marketed by ZENITH PHARMA and is among the pharmaceutical specialties referenced by the Ministry of Health.
For any question about the use, effects, or drug interactions of Co-Arapro 300 mg / 25 mg, consult your doctor or pharmacist. This information is provided for educational purposes and does not replace medical advice.
Frequently Asked Questions about Co-Arapro 300 mg / 25 mg
Answers to common questions from Moroccan patients about this drug.